Roy Decker, MD/PhD

Associate Professor of Therapeutic Radiology and Assistant Professor of Surgery (Otolaryngology); Clinical Research Program Leader, Therapeutic Radiology, Yale Cancer Center

Clinical Interests

  • Radiation Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Child
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Head and Neck Cancer Surgery Program | Thoracic Oncology Program

Radiation Oncology

Therapeutic Radiology/Radiation Oncology: Head and Neck Radiotherapy Program | Spine Radiosurgery Program | Therapeutic Radiology - Patient Care | Thoracic/Stereotacticbody Radiotherapy Program

Yale Medical Group

Board Certifications

  • Therapeutic Radiology AB of Radiology (2008)

Clinical Trials

Conditions Study Title
Unknown Sites An Investigation of Tumor-Derived Mutated DNA in the Blood and Urine as a Biomarker for Cancer Treatment Response
Larynx, Lip, Oral Cavity and Pharynx RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer {CIRB}
Prostate Genitourinary Cancer Data and Specimen Repository
Brain and Nervous System, Other Respiratory and Intrathoracic Organs A randomised, double-blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa, or IVb loco-regionally advanced head and neck squamous cell carcinoma
Rectum KD018: Pilot Trial of KD018 with Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Lung Non-invasive Imaging of Tumor Hypoxia in Non-small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
Larynx, Lip, Oral Cavity and Pharynx Yale Head and Neck Tissue Biorepository
A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy with Carboplatin and Paclitaxel for Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC), (S1206/NCI Study Number 8811)
Unknown Sites Molecular Predictors of Radiation Resistance
Larynx, Lip, Oral Cavity and Pharynx RTOG 1216: Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck {CIRB}
Lip, Oral Cavity and Pharynx ECOG 3311: Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Unknown Sites In Vivo biodosimetry using electron paramagnetic resonance (EPR) spectroscopy
Soft Tissue RTOG 3501 (TRYHARD): A PHASE II, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF LAPATINIB (TYKERB®) FOR NON-HPV LOCALLY ADVANCED HEAD AND NECK CANCER WITH CONCURRENT CHEMORADIATION
Lung, Melanoma, skin A Phase I/II Trial of Evaluating the Combination of MK-3475 and Stereotactic Body Radiotherapy in Patients with Metastatic Melanoma or NSCLC
Soft Tissue NRG-HN001: RANDOMIZED PHASE II AND PHASE III STUDIES OF INDIVIDUALIZED TREATMENT FOR NASOPHARYNGEAL CARCINOMA BASED ON BIOMARKER EPSTEIN BARR VIRUS (EBV) DEOXYRIBONUCLEIC ACID (DNA)

Edit this profile

Contact Info

Roy Decker, MD/PhD
Patient Care Locations
Yale Therapeutic RadiologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste Lower Level

New Haven, CT 06511
Yale-New Haven Shoreline Medical Center
111 Goose Lane

Guilford, CT 06437
Laboratory for Medicine and Pediatrics
15 York Street

New Haven, CT 06510
Yale-New Haven Hospital
20 York Street

New Haven, CT 06510
Norwalk Hospital
34 Maple Street

Norwalk, CT 06856
Lawrence & Memorial Hospital
365 Montauk Avenue

New London, CT 06320
Greenwich Hospital - 5 Perryridge Road
5 Perryridge Rd

Greenwich, CT 06830
5520 Park Avenue
Trumbull, CT 06611
Mailing Address
PO Box 208040
New Haven, CT 06520-8040